Brevan Howard Capital Management’s AbbVie ABBV Stock Holding History

Brevan Howard Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29M	Buy	115,264 +41,681	+57%	+$8.97M	0.21%	67
2026 Q1	$16M	Buy	+73,583	New	+$16.3M	0.14%	87
2025 Q4	–	Sell	-18,338	Closed	-$4.25M	–	1717
2025 Q3	$4.25M	Sell	18,338 -26,408	-59%	-$5.38M	0.02%	284
2025 Q2	$8.31M	Sell	44,746 -21,797	-33%	-$4.05M	0.05%	229
2025 Q1	$13.9M	Buy	+66,543	New	+$12.9M	0.13%	46
2024 Q4	–	Sell	-25,820	Closed	-$5.1M	–	994
2024 Q3	$5.1M	Buy	25,820 +23,832	+1,199%	+$4.45M	0.04%	125
2024 Q2	$341K	Buy	+1,988	New	+$329K	﹤0.01%	732
2024 Q1	–	Sell	-12,727	Closed	-$1.97M	–	963
2023 Q4	$1.97M	Buy	+12,727	New	+$1.86M	0.02%	125

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brevan Howard Capital Management's ABBV Position: Q2 2026 in Review

Brevan Howard Capital Management increased its AbbVie (ABBV) stake by 57% in Q2 2026, buying an estimated $8.97M and bringing the position to 115,264 shares worth $29M. The position accounts for 0.21% of the portfolio, ranked #67.

Brevan Howard Capital Management first reported a position in ABBV in Q4 2023 and has held it in 8 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Brevan Howard Capital Management held 115,264 shares of AbbVie worth $29M as of Q2 2026.
Brevan Howard Capital Management bought 41,681 AbbVie shares in Q2 2026, an estimated $8.97M.
AbbVie made up 0.21% of Brevan Howard Capital Management's portfolio in Q2 2026, its #67 holding.
Brevan Howard Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 8 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.